Skip to main content
Premium Trial:

Request an Annual Quote

The Impact of Reaching Out

Outreach projects are expected of researchers by many funding groups, but there are other reasons to get involved, writes Dave Hone, a University of Bristol researcher at the Lost Worlds blog, including as a way for researchers to publicize their work or to present real data to the public.

Hone notes that studies that are covered by the media tend to become more highly cited, so that could, in turn, help researchers' careers. In addition, he says that discussing his work with a number of different audiences and in different formats has helped him. "I think my ability as a lecturer and my ability to write scientific papers has improved in part because of the outreach work I do," he says.

And then that outreach can have an effect on others. "It sounds horribly trite to say that this kind of thing inspires the next generation of scientists, but it really seems to be true," Hone adds. "Feedback I've had from students, schoolchildren, teachers, parents and others all point to the outreach efforts of various academics having a genuinely positive effect on numerous young people."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.